These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7723497)

  • 1. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty.
    Samani NJ; Martin DS; Brack M; Cullen J; Chauhan A; Lodwick D; Harley A; Swales JD; de Bono DP; Gershlick AH
    Lancet; 1995 Apr; 345(8956):1013-6. PubMed ID: 7723497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty.
    Hamon M; Bauters C; Amant C; McFadden EP; Helbecque N; Lablanche JM; Bertrand ME; Amouyel P
    Circulation; 1995 Aug; 92(3):296-9. PubMed ID: 7634441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty.
    van Bockxmeer FM; Mamotte CD; Gibbons FA; Burke V; Taylor RR
    Circulation; 1995 Oct; 92(8):2066-71. PubMed ID: 7554183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
    Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
    Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
    Völzke H; Hertwig S; Rettig R; Motz W
    Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.
    Koch W; Kastrati A; Mehilli J; Böttiger C; von Beckerath N; Schömig A
    Circulation; 2000 Jul; 102(2):197-202. PubMed ID: 10889131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E polymorphism does not predict risk of restenosis after coronary angioplasty.
    Samani NJ; Martin DS; Brack M; Cullen J; Wallis R; Lodwick D; Chauhan A; Harley A; Thompson JR; Gershlick AH; de Bono DP
    Atherosclerosis; 1996 Sep; 125(2):209-16. PubMed ID: 8842352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
    Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
    Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE gene polymorphism and coronary restenosis.
    Bauters C; Amouyel P; Bertrand ME
    Semin Interv Cardiol; 1999 Sep; 4(3):145-9. PubMed ID: 10545620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting.
    Gürlek A; Güleç S; Karabulut H; Bokesoy I; Tutar E; Pamir G; Alpman A; Toydemir R; Aras O; Oral D
    J Cardiovasc Risk; 2000 Dec; 7(6):403-7. PubMed ID: 11155292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis.
    Bauters C; Amouyel P
    Eur Heart J; 1998 Sep; 19 Suppl J():J24-9. PubMed ID: 9796837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.
    Guneri S; Baris N; Aytekin D; Akdeniz B; Pekel N; Bozdemir V
    Int Heart J; 2005 Sep; 46(5):889-97. PubMed ID: 16272779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ace D/I polymorphism and incidence of post-PTCA restenosis: a prospective, angiography-based evaluation.
    Zee RY; Fernandez-Ortiz A; Macaya C; Pintor E; Lindpaintner K; Fernandez-Cruz A
    Hypertension; 2001 Mar; 37(3):851-5. PubMed ID: 11244007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis.
    Ribichini F; Ferrero V; Matullo G; Feola M; Vado A; Camilla T; Guarrera S; Carturan S; Vassanelli C; Uslenghi E; Piazza A
    Clin Sci (Lond); 2004 Oct; 107(4):381-9. PubMed ID: 15101817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting.
    Amant C; Bauters C; Bodart JC; Lablanche JM; Grollier G; Danchin N; Hamon M; Richard F; Helbecque N; McFadden EP; Amouyel P; Bertrand ME
    Circulation; 1997 Jul; 96(1):56-60. PubMed ID: 9236417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
    Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
    Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.
    Samani NJ; O'Toole L; Martin D; Rai H; Fletcher S; Lodwick D; Thompson JR; Morice AH; Channer K; Woods KL
    J Am Coll Cardiol; 1996 Aug; 28(2):338-44. PubMed ID: 8800107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [D/D genotype of the gene for angiotensin converting enzyme as a risk factor for post-stent coronary restenosis].
    Guarda E; Fajuri A; Marchant E; Martínez A; Jalil J; Illanes G; Vecchiola A; Lazen R; Flores A; Barra V; Irarrázabal S; Ilabaca F
    Rev Esp Cardiol; 1999 Jul; 52(7):475-80. PubMed ID: 10439670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.